Citeline (Trialtrove, Pharmaprojects, Sitetrove) is deep, hand-curated trial and pipeline data. One Zyme reasons across that same evidence plus patents, filings, financings, and literature, and returns the answer, not just the records.
Citeline is trusted for trial and pipeline curation. But strategy questions rarely stop at a trial record, and Citeline leaves the connecting to you.
One Zyme links a trial to its patents, its sponsor’s financing, competing programs, and the underlying science, so the record becomes a decision, not a data point.
Citeline’s China depth trails its Western coverage. One Zyme reads China’s regulatory, clinical, and corporate sources natively and in real time.
No Boolean syntax or module-hopping. Ask a real question and get a cited synthesis your team can act on immediately.
One-size-fits-all records; you adapt them to your priorities.
Query trial/pipeline databases; build the analysis manually.
Strong on trials & pipeline; other signals live elsewhere.
Western coverage leads; China arrives later.
Curated records; interpretation is manual.
Curation cadence introduces lag.
Multiple products, separate subscriptions.
See One Zyme run live on a target of your choice, and compare the answer to what your current stack returns.
